

The 57th Cosmoprof Bologna (March 26–29, 2026) revealed that Chinese beauty device manufacturers with CE+MDR dual certification and IEC 60601-2-57 clinical safety reports received concentrated inquiries from European and American distributors. Products without medical-grade certification, despite being 30% cheaper, saw a 65% drop in purchase intent. This event highlights how certification progress has become a critical differentiator for Chinese suppliers in the international market. The beauty device manufacturing, export, and distribution sectors should pay close attention to these developments, as they signal shifting buyer priorities and regulatory requirements.
The 57th edition of Cosmoprof Bologna, held from March 26 to 29, 2026, demonstrated a clear trend in the beauty device market. Chinese manufacturers offering dual-mode RF/LED devices with complete CE+MDR certification and IEC 60601-2-57 clinical safety documentation attracted significant attention from European and American buyers. In contrast, similar products lacking medical-grade certification, despite their lower price points, experienced substantially reduced interest from international distributors.
Export-oriented Chinese beauty device manufacturers face immediate impact. Those with completed certifications are seeing increased business opportunities, while uncertified competitors are losing market share. The divide between certified and non-certified suppliers is becoming more pronounced in international procurement decisions.
Testing and certification service providers specializing in medical device standards are experiencing growing demand. The need for IEC 60601-2-57 compliance reports in particular is creating new business opportunities for qualified laboratories and consultants.
European and American distributors are adjusting their sourcing strategies, prioritizing certified suppliers despite higher costs. This shift reflects changing market requirements and consumer expectations for safety-assured products.
Manufacturers should accelerate CE+MDR certification and IEC 60601-2-57 compliance testing. The timeline for completing these processes now directly correlates with market access and competitiveness.
The traditional low-price advantage is diminishing in this segment. Companies should analyze whether current pricing models adequately reflect the value of certified products in target markets.
Comprehensive clinical safety reports have become a key differentiator. Investing in thorough, professionally prepared documentation can significantly improve buyer confidence and negotiation position.
Stay updated on potential changes to EU medical device regulations and similar standards in other target markets, as these may further impact certification requirements.
From an industry perspective, this development signals a maturation of the international beauty device market. The emphasis on medical-grade certifications suggests that buyers are prioritizing safety and compliance over price alone. This trend is likely to continue as regulatory frameworks evolve and consumer awareness grows. The current situation appears to be more than just a temporary shift - it may represent a fundamental change in market requirements that will shape the industry for years to come.
The Cosmoprof Bologna 2026 outcomes demonstrate that certification status has become a decisive factor in the global beauty device market. For Chinese manufacturers, adapting to these requirements is no longer optional but essential for maintaining international competitiveness. The industry should view this development as both a challenge and an opportunity to align with higher standards and access more premium market segments.
Primary source: Official reports from Cosmoprof Bologna 2026 (March 26-29). Additional data from exhibition participant interviews and procurement trend analyses. The long-term impact of these developments on different market segments remains to be fully observed as the 2026 business cycle progresses.
Related Intelligence